Pinatuzumab, CAS 1639820-81-7

Product Description: Pinatuzumab is a CD22 monoclonal antibody. Pinatuzumab targets the cell-surface antigen CD22. Pinatuzumab can be used for synthesis of antibody agent conjugates (ADCs) to research several diseases including non-Hodgkin lymphoma (NHL)[1][2].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]June Ereño-Orbea, et al. Structural Basis of Enhanced Crystallizability Induced by a Molecular Chaperone for Antibody Antigen-Binding Fragments. J Mol Biol. 2018 Feb 2;430(3):322-336/[2]Shang-Fan Yu, et al. An Anti-CD22- seco-CBI-Dimer Antibody-Drug Conjugate (ADC) for the Treatment of Non-Hodgkin Lymphoma That Provides a Longer Duration of Response than Auristatin-Based ADCs in Preclinical Models. Mol Cancer Ther. 2021 Feb;20(2):340-346.

CAS Number: 1639820-81-7

Molecular Weight: N/A

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD22;Integrin

• SKU: MEXHY-P99230-5
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99230-5
• Green Labware: No
• Package Unit: 5mg
• Quantity Unit: STK